Clinical trial
Early Administration of Long-acting Insulin Glargine for the Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes: A Randomized Double Blind Trial
NCT02548494 is registered in ClinicalTrials.gov with Chattanooga-Hamilton County Hospital Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Administration of Long-acting Insulin Glargine for the Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes: A Randomized Double Blind Trial
- Lead sponsor
- Chattanooga-Hamilton County Hospital Authority
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 30, 2015
- Completion date
- February 1, 2019
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.